PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Feb-2023 Vaginal and Vulval Inflammatory Disease Treatment Market is predicted to rise 5.8% CAGR by 2033 MARKITWIRED
01-Feb-2023 Frontotemporal Dementia Management is expected to register CAGR 6% through 2033 MARKITWIRED
01-Feb-2023 Dystrophic Epidermolysis Bullosa Management Market to reach US$ 787.8 Million by 2033 MARKITWIRED
01-Feb-2023 Global Hyperpigmentation Treatment Market expected to reach US$ 11.84 billion by 2033 MARKITWIRED
01-Feb-2023 Large Molecule Bioanalytical Testing Service Market is projected to grow at a CAGR 12.1% from 2023 to 2033 MARKITWIRED
01-Feb-2023 Advicenne Provides an Update on Its Commercial Partnerships in Europe and the Middle East Businesswire
01-Feb-2023 JelikaLite Announces Positive Results From a New Feasibility Study, Successful Raise of $760,000 and Acceptance into Mount Sinai Elementa Labs Program Businesswire
01-Feb-2023 Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market Businesswire
01-Feb-2023 JelikaLite Announces Positive Results From a New Feasibility Study, Successful Raise of $760,000 and Acceptance into Mount Sinai Elementa Labs Program Businesswire
01-Feb-2023 Constellation Receives Growth Investment from Newlight Partners to Accelerate Expansion into New Markets and Sectors Businesswire
01-Feb-2023 Velentium and ADV Integrity Announce Sale of Oil & Gas Division Businesswire
01-Feb-2023 Award-winning Author and Adviser Safi Bahcall to Take Center Stage of IAMPHENOM Businesswire
01-Feb-2023 Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market B3C newswire
01-Feb-2023 Orangewood Partners Sells Kentucky-Based Taco Bell Franchisee Businesswire
01-Feb-2023 Formycon AG announces global license agreement with Fresenius Kabi for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab) Formycon AG
01-Feb-2023 Formycon AG plans capital increase of approx. 5% of the share capital by way of an accelerated bookbuilding procedure to finance further growth Formycon AG
01-Feb-2023 Invacare Corporation Takes Action to Strengthen Its Financial Position and Drive Long-Term Growth Through Voluntary Prearranged Chapter 11 Cases That Do Not Include Its International Operations Businesswire
01-Feb-2023 Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Breast Cancer with a HER2 Mutation Businesswire
01-Feb-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
01-Feb-2023 Dragos Appoints Former Intelligence Community Expert Kurt Gaudette as Vice President of Global Threat Intelligence Businesswire